Graham P. Allaway
Plus aucun poste en cours
Profil
Graham P.
Allaway was Chief Operating Officer of Panacos Pharmaceuticals, Inc. from May 3, 2005 to February 27, 2009.
Dr. Allaway was Senior Vice President for Drug Discovery at Boston Biomedica Inc., which he joined in 1998.
Prior to this, he was Chief Executive Officer of Manchester Biotech from 1997 to 1998.
Dr. Allaway received his MA in Zoology from the University of Oxford and his PhD in Virology from the University of London.
Anciens postes connus de Graham P. Allaway
| Sociétés | Poste | Fin |
|---|---|---|
| PANACOS PHARMACEUTICALS, INC. | Fondateur | 27/02/2009 |
Panacos Pharmaceuticals, Inc. /Old/
 Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | President | 03/03/2005 |
Manchester Biotech
 Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | President | 01/01/1998 |
| PRESSURE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formation de Graham P. Allaway
| University of Oxford | Graduate Degree |
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Panacos Pharmaceuticals, Inc. /Old/
Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Commercial Services |
Manchester Biotech
Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | Health Technology |